← Back
$CPRX All transactions

CATALYST PHARMACEUTICALS, INC.

M

$ Value

Shares

14,000

Price

Filed

Dec 30

Insider

Name

Miller Steve

Title

Chief Op. & Scientific Officer

CIK

0001402535

Roles

Officer

Transaction Details

Transaction Date

2025-12-29

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,093,803

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. | Derivative securities vested in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025. | Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 29, 2025.

Filing Info

Accession No.

0001161697-25-000494

Form Type

4

Issuer CIK

0001369568

Miller Steve's History

Date Ticker Type Value
2025-12-29 CPRX M
2025-12-29 CPRX M $0
2025-12-08 CPRX M
2025-12-08 CPRX M $0
2025-11-21 CPRX M
2025-11-21 CPRX M $0
2025-11-20 CPRX A $0
2025-11-20 CPRX A $0
2025-08-27 CPRX M $246K
2025-08-27 CPRX M $0

Other Insiders at CPRX (90d)

Insider Bought Sold Last
Russo Gregg
Chief HR Officer
2026-02-17